BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lei GL, Niu Y, Cheng SJ, Li YY, Bai ZF, Yu LX, Hong ZX, Liu H, Liu HH, Yan J, Gao Y, Zhang SG, Chen Z, Li RS, Yang PH. Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma. World J Gastroenterol 2021; 27(20): 2586-2602 [PMID: 34092977 DOI: 10.3748/wjg.v27.i20.2586]
URL: https://www.wjgnet.com/1948-5182/full/v27/i20/2586.htm
Number Citing Articles
1
Bing Jiang, Kankan Yang, Chao Tang, Rui Chen, Chao Wang. LncRNA LINC01270 aggravates the progression of gastric cancer through modulation of miR-326/EFNA3 axisBioengineered 2022; 13(4): 8995 doi: 10.1080/21655979.2022.2054204
2
Chou Yang, Lingyan Zhang, Xin Hao, Mengdie Tang, Bin Zhou, Jinlin Hou. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment VerificationCurrent Oncology 2022; 30(1): 430 doi: 10.3390/curroncol30010035
3
Guozheng Pan, Jian Zhang, Faping You, Tao Cui, Peng Luo, Shuling Wang, Xiaomei Li, Qingzhong Yuan. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1Bioengineered 2022; 13(1): 1346 doi: 10.1080/21655979.2021.2017565
4
Swarnalatha Kodidela, Abhayananda Behera, Aramati Bindu Madhava Reddy. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 341 doi: 10.1016/B978-0-323-98806-3.00020-9
5
Yanan Yang, Yongqing Li, Haonan Yuan, Xuanbo Liu, Yue Ren, Caixia Gao, Ting Jiao, Yuan Cai, Shengguo Zhao. Integrative Analysis of the lncRNA-Associated ceRNA Regulatory Network Response to Hypoxia in Alveolar Type II Epithelial Cells of Tibetan PigsFrontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.834566
6
Ahmad Khan, Xiaobo Zhang. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic PotentialsBioengineering 2022; 9(8): 406 doi: 10.3390/bioengineering9080406
7
Fatemeh Movahedi Motlagh, Sepideh Kadkhoda, Maryam Motamedrad, Parisa Javidzade, Sheyda Khalilian, Mohammad Hossein Modarressi, Soudeh Ghafouri-Fard. Roles of non-coding RNAs in cell death pathways involved in the treatment of resistance and recurrence of cancerPathology - Research and Practice 2023; 247: 154542 doi: 10.1016/j.prp.2023.154542
8
Qian Liu, Chunfu Zhu, Yanfen Dong. LncRNA TCTN2 Promotes the Malignant Development of Hepatocellular Carcinoma via Regulating mIR-1285-3p/ARF6 AxisRecent Patents on Anti-Cancer Drug Discovery 2023; 18(4): 517 doi: 10.2174/1574892818666221019163656
9
Juan Lu, Zhaoying Xiao, Mengqiu Xu, Lanjuan Li. New Insights into LINC00346 and its Role in DiseaseFrontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.819785
10
Qi Wang, Qiong Fang, Yanping Huang, Jin Zhou, Meimei Liu. Identification of a novel prognostic signature for HCC and analysis of costimulatory molecule-related lncRNA AC099850.3Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13792-z
11
I. Saranya, V. Sowfika Dharshini, R.L. Akshaya, P. Sakthi Subhashini, N. Selvamurugan. Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A reviewInternational Journal of Biological Macromolecules 2024; 266: 131075 doi: 10.1016/j.ijbiomac.2024.131075